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A detergent-free strategy for the reconstitution of
active enzyme complexes from native biological
membranes into nanoscale discs
Ashley R Long1, Catherine C O’Brien1, Ketan Malhotra1, Christine T Schwall1, Arlene D Albert1, Anthony Watts2
and Nathan N Alder1*
Abstract
Background: The reconstitution of membrane proteins and complexes into nanoscale lipid bilayer structures has
contributed significantly to biochemical and biophysical analyses. Current methods for performing such
reconstitutions entail an initial detergent-mediated step to solubilize and isolate membrane proteins. Exposure to
detergents, however, can destabilize many membrane proteins and result in a loss of function. Amphipathic
copolymers have recently been used to stabilize membrane proteins and complexes following suitable detergent
extraction. However, the ability of these copolymers to extract proteins directly from native lipid bilayers for
subsequent reconstitution and characterization has not been explored.
Results: The styrene-maleic acid (SMA) copolymer effectively solubilized membranes of isolated mitochondria and
extracted protein complexes. Membrane complexes were reconstituted into polymer-bound nanoscale discs along
with endogenous lipids. Using respiratory Complex IV as a model, these particles were shown to maintain the
enzymatic activity of multicomponent electron transporting complexes.
Conclusions: We report a novel process for reconstituting fully operational protein complexes directly from cellular
membranes into nanoscale lipid bilayers using the SMA copolymer. This facile, single-step strategy obviates the
requirement for detergents and yields membrane complexes suitable for structural and functional studies.
Keywords: Styrene-maleic acid, Copolymer, Amphipols, Membrane proteins, Nanoscale model membranes,
Mitochondria, LipodisqsW
Background
Integral membrane proteins are vital to cellular function.
They represent nearly a third of all gene products and
account for roughly half of all current pharmaceutical
targets [1,2]. These proteins are embedded in the
membrane bilayer, which supports the lipid and pro-
tein interactions essential for protein function and
structural stability. The transmembrane segments of
integral membrane proteins are enriched in hydropho-
bic side chains that are in direct contact with lipid acyl
chains or with the nonpolar surfaces of other transmem-
brane segments. Without suitable detergents, membrane
proteins denature or aggregate during extraction pro-
cedures. Therefore, solution-based analysis of isolated
membrane proteins and protein complexes requires an
experimental means of shielding their hydrophobic
surfaces from water.
Detergent solubilization is commonly used to isolate
and characterize membrane proteins. Yet the identification
of a detergent that is compatible with a given target protein
can be a challenge. More critically, detergent micelles are
often unsatisfactory substitutes for lamellar membranes.
Native lipid bilayers present specific physical and
chemical properties to an integral membrane protein
in the interfacial and nonpolar regions and generate an
environment that is critical for membrane protein
function, stability and folding [3-6]. Such an environ-
ment is not well represented in micellar structures. In
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addition, detergents can displace functionally relevant
annular lipids. Thus, it has long been observed that
many integral membrane proteins can denature and
lose function once removed from the bilayer by deter-
gent solubilization [6-12].
Several types of model membrane systems have therefore
been developed that more closely mimic the lamellar lipid
bilayer of native membranes. Proteoliposomes, synthetic
lipid vesicles containing membrane proteins, provide such
an environment. However, they can be heterogeneously
sized and may promote protein aggregation. Further,
their large size (up to several microns in diameter)
makes them unsuitable for many spectroscopy tech-
niques due to scattering or low rotation rates, and their
vesicular structure precludes direct experimental ac-
cess to both sides of the bilayer [13]. To address these
technical issues, discoidal nanoscale lipid bilayers have
been developed for membrane protein reconstitution.
These include bicelles and nanodiscs. In bicelles, the
rim of the lipid bilayer disc is stabilized by surfactants
or by short-chain lipids [14,15]; in nanodiscs, the lipid
discoid is bound by an amphipathic scaffolding protein
[6,13]. These model membranes have been successfully
used for both spectroscopic and structural studies
[13,14,16-18]. However, bicelles require very specific
combinations of lipids that may not be commensurate
with the native bilayer and may not provide the opti-
mal lipid environment for the protein of interest.
Nanodiscs have no such specific lipid requirement;
however, the reconstitution of membrane proteins into
nanodics stabilized by a scaffolding protein requires an
initial detergent solubilization step. Thus, it may be
difficult to quantitatively remove the potentially desta-
bilizing detergents following their assembly or to
deconvolute the contribution of the scaffolding protein
from the reconstituted membrane protein.
More recently, amphipathic polymers (amphipols) have
emerged as a detergent-free means of membrane protein
solubilization [6,15,19-21]. Amphipols likely form torroids
around the transmembrane domains of membrane
proteins, with the inner and outer polymer surfaces
comprising nonpolar and polar pendant groups, re-
spectively. Amphipols were originally developed to
maintain membrane protein solubility after treatment
with a nondenaturing detergent. The amphipols PMAL-
B-100 and A8-35, for example, have been used to main-
tain the solubility [22] and catalytic activity [23] of a range
of proteins, even very large (1.7 MDa) multisubunit com-
plexes from mitochondrial membranes [24].
Amphipols have not typically been used for the ex-
traction of membrane proteins from lipid bilayers.
However, a copolymer prepared from a 3:1 molar ratio
of styrene to maleic acid (3:1 SMA, Figure 1) has been
previously shown to solubilize lipids from vesicles of
1,2-dimyristoyl-sn-phosphocholine (DMPC), forming mono-
disperse disc-shaped polymer-lipid complexes 9–10 nm in
diameter, termed LipodisqsW [25]. This SMA copolymer
has also been shown to extract the α-helical bundle
protein bacteriorhodopsin [26,27] and the β-barrel protein
PagP [27] from DMPC vesicles. The resulting lipid- and
protein-containing particles had a larger diameter (11–
12 nm) than empty discs and maintained the protein ac-
tivity [26,27]. These investigations demonstrated that
SMA could be used to extract membrane proteins that
have been previously reconstituted into bilayers of syn-
thetic phospholipids. They also highlighted the intri-
guing possibility that amphipols can be used in place of
detergents for membrane protein reconstitution into
soluble lipid nanoparticles. In the present study, we
demonstrate for the first time that it is possible to extract
functional membrane complexes directly from native
biological membranes without prior detergent-mediated
isolation or reconstitution. To this end, we tested whether
the SMA copolymer could both disrupt membranes of
mitochondria isolated from yeast (Saccharomyces cerevisiae)
and extract functional membrane complexes.
Results and discussion
The SMA copolymer solubilizes native mitochondrial
membranes
Mitochondria contain two protein-rich membranes, with
the topologically complex inner membrane (IM) subdivided
into the inner boundary membrane and the cristae
membrane (Figure 2A). The respiratory complexes of
Figure 1 The chemical structure of the SMA copolymer. The 3:1
SMA copolymer consists of heterogeneously coupled hydrophobic
styrene and hydrophilic maleic acid pendant groups.
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the IM generate a redox-coupled proton gradient
across the IM, the majority of which is stored as a
transmembrane electric potential (Δψm, 150–180 mV;
Figure 2A) [28]. We first determined whether SMA
could disrupt the IM by testing its ability to dissipate
this ion gradient in actively respiring mitochondria.
The relative Δψm can be assessed by the fluorescent
potentiometric probe tetramethyl rhodamine methyl
ester (TMRM), whose fluorescence intensity decreases
with increasing membrane potential [29-31]. TMRM
can thus be used as a reporter for membrane integrity,
because an intact IM is required to generate and maintain
a measurable Δψm. As a positive control, we confirmed
that the addition of detergent [n-dodecyl-β-D-maltoside
(DDM)] dissipated the ion gradient across the IM as it
solubilized the membranes (Figure 2B). Interestingly,
the addition of the SMA copolymer dissipated the ion
gradient to a similar extent as detergent, indicating that
it also disrupted the integrity of the IM (Figure 2C). As
a negative control, the addition of SMA buffer by itself
had no effect on the mitochondrial membrane potential
(Figure 2D). The K+ ionophore valinomycin was added
at the end of each time course to cause the complete
collapse of the Δψm. Following DDM or SMA addition,
there was no additional valinomycin-induced increase
in TMRM fluorescence, indicating that the ion gradients
had been completely collapsed in both cases. We therefore
conclude that the SMA copolymer effectively disrupted
the integrity of the IM.
SMA extracts membrane proteins from the mitochondrial IM
To analyze directly the ability of the SMA copolymer
to extract mitochondrial membrane complexes, we first
employed Blue Native Polyacrylamide Gel Electrophoresis
(BN-PAGE) [32,33]. It has been amply demonstrated
that multicomponent complexes solubilized from mito-
chondrial membranes with mild nonionic detergents
such as DDM remain intact and can be resolved by
native electrophoresis [34-37]. Thus, we subjected
mitochondria to incubation with increasing amounts
of DDM or the SMA copolymer, removed non-solubilized
membrane by centrifugation, and analyzed the super-
natants by BN-PAGE and Coomassie G-250 staining.
We found that incubation of mitochondria with in-
creasing amounts of SMA resulted in the extraction of
large complexes (Figure 3A, lanes 1–5) that resolved as
discrete bands with apparent molecular weights compar-
able to those solubilized by DDM (Figure 3A, lanes 6–10).
Taken together, the results shown in Figures 2 and 3
confirm that the SMA copolymer can solubilize the
native membranes of mitochondria, and does extract
large protein complexes.
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Figure 2 Disruption of mitochondrial membranes by the SMA copolymer. (A) Schematic of mitochondrial subcompartments and location of
protein complexes analyzed in this study. Subunits of the TIM23 Complex and respiratory Complex II (cyan) were analyzed by immunodetection
and respiratory Complex IV (green) was analyzed for enzyme activity. (B-D) Time course measurements of TMRM fluorescence were conducted
with the addition of the following to actively respiring mitochondria: (B) DDM (final concentration 0.4% (w/v), (C) the SMA copolymer
(final concentration 1 g SMA : 1 g mitochondrial protein), and (D) SMA buffer only. Valinomycin was added at the end of each time course to
completely collapse the membrane potential.
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We next used Western blotting to demonstrate un-
equivocally that the SMA copolymer extracted integral
membrane proteins from the mitochondrial membranes,
and did not simply release proteins that were peripher-
ally bound. Following incubation with SMA and DDM
as above, mitochondrial extracts were resolved by de-
naturing gel electrophoresis and probed by immuno-
blotting with antisera against two integral membrane
proteins: the Sdh3 subunit of respiratory Complex II
(located in the cristae) and the Tim50 subunit of the
TIM23 protein transport complex (located in the inner
boundary membrane) (see Figure 2A). We found that
both proteins were detected in mitochondrial extracts
following incubation with DDM (Figure 3B, lanes 5 and
10 respectively) and with sufficient concentrations of the
SMA copolymer (Figure 3B, lanes 4 and 9 respectively).
Based on band quantification, the amount of Tim50
extracted by SMA at the concentration used was nearly
equivalent (within 5%) to the amount extracted by
DDM. By contrast, with the same SMA concentration,
the amount of Sdh3 extracted was approximately 30%
of that extracted by DDM. This difference in SMA ex-
traction efficiency may be related to the location of the
membrane protein within the morphologically com-
plex inner membrane, and it suggests that SMA-based
extraction conditions must be optimized on a protein-
specific basis. Nonetheless, these results confirm that
the SMA copolymer does extract integral membrane
proteins from cellular membranes.
SMA solubilization of mitochondrial membranes yields
discoidal nanoparticles
To assess the size and shape of SMA particles formed
after incubation with mitochondria, we visualized the
extracts by transmission electron microscopy (TEM)
following fractionation by size exclusion chromatography
(SEC). The gel filtration chromatogram of these extracts
(Figure 4A) shows that particles formed from native
mitochondrial membranes had a broad size range. This
is in contrast to the monodisperse peaks previously ob-
served following the extraction of single types of mem-
brane proteins from synthetic bilayers [26,27]. However,
our results are not unexpected given the large range of
protein complex sizes that exist within the membranes
of mitochondria and are consistent with the broad
molecular weight range of extracted complexes detected
by BN-PAGE (Figure 3A).
Samples from the fraction denoted by an asterisk on the
SEC chromatogram were chosen for imaging because this
fraction displayed robust mitochondrial enzymatic activity
(see the following section). The TEM image of this
fraction (Figure 4B) revealed a monodisperse popula-
tion of SMA-stabilized discoidal nanoparticles consist-
ent with those observed in previous reports [26,27].
We therefore conclude that the SMA copolymer can
solubilize native cellular membranes and stabilize the
bilayers as discoidal, polymer-bound particles. Here-
after these SMA-bound nanoparticles will be termed
mitochondrial-LipodisqsW.
Respiratory Complex IV in SMA nanoparticles is
functionally active
To confirm the ability of mitochondrial-LipodisqsW to
support the function of extracted membrane complexes,
we analyzed the activity of respiratory Complex IV
(cytochrome c oxidase, Figure 2A) as a model. Com-
plex IV consists of a catalytic core of three subunits
(Cox1, Cox2 and Cox3) and multiple additional proteins
(eight in yeast, ten in mammals) (Figure 5A) [38-41]. As
the terminal enzyme of the electron transport chain,
Complex IV catalyzes the oxidation of ferrocytochrome
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Figure 3 Extraction of mitochondrial membrane proteins by
the SMA copolymer. (A) BN-PAGE analysis of proteins extracted
from isolated mitochondria following incubation with increasing
concentrations of SMA copolymer (lanes 1 to 5) or DDM
(lanes 6 to 10). Arrows indicate locations of detectable bands.
(B) Immunodetection of Sdh3 (left panel, lanes 1–5) and Tim50
(right panel, lanes 6–10) extracted from mitochondria by SMA and
DDM at the concentrations indicated.
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c and the reduction of molecular oxygen to water,
pumping protons into the intermembrane space in the
process (Figure 5B).
We assayed Complex IV activity spectrophotometrically
by the decrease in absorbance at 550 nm resulting from the
oxidation of pre-reduced cytochrome c. As shown previ-
ously (e.g., [37]) Complex IV maintained potassium cyanide
(KCN)-sensitive activity following the solubilization of
mitochondria by nonionic detergent [0.4% (w/v) DDM,
Figure 5C, left panel]. We observed similar robust Com-
plex IV activity in mitochondrial-LipodisqsW formed upon
incubation with the SMA copolymer (final concentra-
tion, 2 g SMA : 1 g mitochondrial protein, Figure 5C, cen-
ter panel), confirming that the enzyme was active within
those particles. To ensure that mitochondria-LipodisqW
preparations were free of contaminating membrane
fragments that could potentially contribute to enzyme
activity, all samples were carefully filtered (0.4 μm) fol-
lowing SMA solubilization (see Methods). To confirm
further that our measured Complex IV activity originated
from SMA-bound particles, we performed negative con-
trols in which mitochondria were subjected to SMA buffer
only, and no enzyme activity was found in those samples
(Figure 5C, right panel).
To measure the specific cytochrome c oxidase activities
in our DDM-solubilized and SMA nanoparticle samples,
we measured the absorption bands of cytochromes a + a3
as an index of Complex IV concentration (Figure 5D).
The α absorption peaks of cytochromes aa3 can be eas-
ily resolved from the α peaks of other respiratory chain
cytochromes, thereby allowing a reliable measure of
Complex IV in each sample [42-44]. Based on these
measurements, we found that the specific Complex IV
activity within mitochondrial-LipodisqW preparations
was comparable to that of DDM-solubilized mitochon-
dria (Table 1).
As an additional means of confirming that Complex
IV remained active within SMA-bound nanoparticles,
we subjected mitochondrial-LipodisqsW to SEC purification
and measured the enzymatic activity of the fraction corre-
sponding to that used for TEM imaging (Figure 4). This
fraction displayed robust and cyanide-sensitive cytochrome
c oxidase activity (Table 2), confirming the presence of
active Complex IV within these particles.
An estimate of the dimensions of these mitochondrial-
LipodisqsW underscores the feasibility of reconstituting
the multisubunit Complex IV holoenzyme into a single
polymer-bound particle. The dimensions for the bovine
homolog of Complex IV (the only high-resolution structure
of the complex solved to date [38,39]) are approximately
9.3 nm × 7.3 nm (Figure 5A). The core subunits of the
complex consist of a total of 14 helical transmembrane
segments (Figure 5A, blue); in yeast, the supernumerary
subunits contribute five additional transmembrane helices
(Figure 5A, green). The dimensions of the mitochondrial-
LipodisqsW formed here (Figure 4B) are consistent
with the previously reported diameter of ~12 nm
(area ~113 nm2) [26]. Therefore, a single particle
could easily accommodate one copy of Complex IV
(area ~50 nm2). Further, assuming an average lipid
cross-sectional area of 0.6 nm2, a discoid of this dimension
could accommodate roughly 100 lipids per leaflet in
addition to a single copy of the enzyme. These estimates of
dimensions and lipid content are similar to those reported
for the photoreceptor bacteriorhodopsin incorporated
into LipodisqsW [26].
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Figure 4 The formation of discoidal SMA-bound nanoparticles. (A) Size exclusion fractionation of SMA particles assembled with
mitochondrial membranes. The chromatogram is absorbance at 280 nm to detect protein content. (B) Electron micrograph of mitochondrial-
LipodisqsW from the SEC fraction denoted by * (scale bar = 100 nm).
Long et al. BMC Biotechnology 2013, 13:41 Page 5 of 10
http://www.biomedcentral.com/1472-6750/13/41
Aintermembrane
space
inner
membrane
matrix
B
cyt. c
H+
O2
e-
H2O
H+
Co
x2
Co
x1
Co
x3
9.3 nm
7.3 nm
C
Time (s) Time (s) Time (s)
A
bs
or
ba
nc
e 
at
 5
50
 n
m
A
bs
or
ba
nc
e 
at
 5
50
 n
m
A
bs
or
ba
nc
e 
at
 5
50
 n
m
DDM SMA MOCK SMA
ΔA = 0.1 ΔA = 0.1 ΔA = 0.1
λ (nm)
D
ΔA = 0.002
aa3
b
cc1
DDM
SMA
Figure 5 Analysis of Complex IV enzymatic activity. (A) Complex IV monomer structure from bovine (PDB 1 V54) with the catalytic core
(blue), supernumerary subunits (green), and subunits absent in yeast (yellow). (B) Schematic of the Complex IV redox pathway with the color
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Table 1 Specific cytochrome c oxidase activity of Complex IV
Sample Specific activity
(nmol cyt. c min-1 pmol cyt. aa3-1)a,b
DDM (no KCN) 7.651 (2.232)
DDM (+ KCN) 0.002 (0.086)
SMA (no KCN) 6.358 (1.098)
SMA (+ KCN) 0.004 (0.033)
aMean values are from a minimum of eight experiments from three
independent preparations.
bNumbers in parenthesis are standard deviations.
Table 2 Cytochrome c oxidase activity of SEC-purified
SMA particles
Sample Cytochrome c oxidation rate
(μM cyt. c min-1)a,b
no KCN 3.350 (0.503)
+KCN 0.017 (0.015)
aMean values are from a minimum of three experiments from three
independent preparations.
bNumbers in parenthesis are standard deviations.
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Taken together, our results confirm that Complex IV
maintains activity in SMA-bound particles. Therefore,
while previous studies have demonstrated the activity of
monomeric proteins (22 to 25 kDa) in LipodisqsW [26,27],
we show here, using Complex IV (ca. 220 kDa) as a
model, that even large, multisubunit complexes can be
reconstituted into these particles from cellular membranes
in a fully operational state.
Mitochondrial LipodisqsW contain lipids from
mitochondria
It has been previously shown that monomeric proteins
reconstituted from synthetic bilayers into LipodisqsW are
surrounded by lipids [26]. By thin-layer chromatography
we confirmed the presence of the major mitochondrial
lipids [phosphatidylcholine (PC), phosphatidylethanolamine
(PE) and cardiolipin (CL)] in the mitochondrial-LipodisqsW
prepared in the present study (Figure 6, lane 5). By contrast,
a control sample (SMA buffer only) revealed no residual
lipids following our preparative steps (Figure 6, lane 4).
These results indicate that lipids as well as intact complexes
were extracted from the mitochondrial membranes and
bound by the SMA copolymer and were thus present in the
mitochondrial-LipodisqsW. These results support the prob-
ability that native lipids are co-reconstituted into the SMA
nanoparticles with the protein complexes.
Conclusions
This study documents for the first time that LipodisqsW
containing isolated protein complexes from cellular
membranes can be formed and used for biochemical and
biophysical analyses. Specifically, we have shown that the
SMA copolymer can disrupt native mitochondrial mem-
branes and extract membrane proteins (Figures 2 and 3)
and native lipids (Figure 6); that mitochondrial LipodisqsW
are SMA-bound discoids with dimensions similar to
previously reported SMA nanoparticles [26,27] (Figure 4);
and that the SMA copolymer can be used to isolate
large multisubunit complexes in a fully-functional state
(Figure 5, Tables 1 and 2). The mechanism by which the
SMA copolymer fragments lipid bilayers into nanometer-
scale discoids is not known. However, the process is highly
pH-dependent, which may be related to conformational
transitions of the hypercoiling SMA polymer that are
dependent on the ionization states of its carboxylate
groups [15,19].
By eliminating the requirement of a detergent-mediated
step, the use of the SMA copolymer represents a sig-
nificant advance in the study of native membrane com-
plexes. As a tool for basic research, LipodisqsW are an
excellent means of analyzing membrane protein acti-
vities and interactions that may be lipid-dependent and
sensitive to detergents. Additionally, these systems
have potential in biophysical studies, in particular where
single (or small numbers of) proteins are required. As a
tool for practical applications, they have potential for the
rapid characterization and diagnosis of dysfunctional
membrane proteins taken directly from tissue samples
of patients with suspected heritable diseases manifest
in membrane proteins.
Methods
Preparation and solubilization of mitochondria
Mitochondria were isolated from Saccharomyces cerevisiae
wild type strain D273-10B as described [45,46], resuspended
in SIB buffer [20 mM HEPES-KOH (pH 7.5), 80 mM
KCl, 5 mM MgCl2, 2 mM potassium phosphate (pH 7.5),
250 mM sucrose, and 0.3% (w/v) bovine serum albu-
min (BSA, fatty acid-free)], frozen in liquid nitrogen
and stored at −80°C until use. For solubilization, mito-
chondria pellets were resuspended to a concentration
of 1 mg mitochondrial protein ml-1 in either SIB buffer
adjusted to pH 8.0 or SB buffer [50 mM Tris (pH 8.0),
200 mM NaCl]. For detergent solubilization, DDM was
added to final concentrations ranging from 0.4 to 6.0%
(w/v) as indicated. For SMA solubilization, lyophilized
3:1 SMA copolymer (Malvern Cosmeceutics Ltd, UK)
was reconstituted as a stock of 25 mg ml-1 in 50 mM
Tris (pH 8.0) as described [25] and added to samples at
final concentrations ranging from 1 g SMA : 8 g mito-
chondrial protein to 2 g SMA : 1 g mitochondrial protein
as indicated. For both DDM and SMA solubilization,
samples were incubated at 26°C for 20 min, centrifuged
(20,000 × g, 10 min, 4°C) and the resulting supernatants
containing solubilized membrane proteins were collected.
CL
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lipid 
standards
1 2 3
mitochondria
samples
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Figure 6 Analysis of mitochondrial lipids contained in SMA
particles. Mitochondria subjected to mock SMA incubation (lane 4)
or incubated with SMA to form mitochondrial-LipodisqsW (lane 5)
were analyzed for lipid content by thin layer chromatography. Lipid
standards are shown in lanes 1–3.
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Further purification steps of SMA-treated samples for
particular applications are described below.
Measurement of membrane potential
The relative membrane potential (Δψm) of isolated
mitochondria was assayed with the fluorescent potentio-
metric probe tetramethyl rhodamine methyl ester (TMRM,
Molecular Probes) as described [47] using a Spex Fluorolog
3–22 spectroflorometer (Horiba Jobin-Yvon). Mitochondria
were diluted to a concentration of 0.1 mg ml-1 in SIB
lacking BSA with 100 nM TMRM (quenching mode)
and kinetics measurements were taken (λex = 547 nm,
λem = 570 nm) with constant stirring of the sample.
Prior to time course measurements, respiratory substrate
(2.5 mM malate and 2.5 mM pyruvate) and 2 mM ATP
were added to establish a maximal Δψm. Subsequent addi-
tions included DDM at a final concentration of 0.4%
(w/v), the SMA copolymer at a final concentration of
1 g SMA : 1 g mitochondrial protein, or an equivalent vo-
lume of SMA buffer only. At the end of each time course,
the potassium ionophore valinomycin was added to a final
concentration of 2.5 μM to completely collapse the Δψm.
Native gel electrophoresis and western blotting
For BN-PAGE analysis, mitochondria were prepared as
above, but resuspended in 50 mM Tris (pH 8.0) prior to
DDM and SMA solubilization. 5X BN-PAGE sample
buffer [50 mM Trizma, 500 mM 6-aminohexanoic acid,
10% (v/v) glycerol, 2% (w/v) Serva Blue G] was added to
supernatants, and 12 μl of each sample were loaded onto
4-15% precast polyacrylamide Mini-Protean TGX gels
(BioRad). The cathode buffer contained 190 mM glycine,
23 mM Tris (pH 8.0) and 0.002% (w/v) Serva Blue G
and the anode buffer consisted of 25 mM Trizma (pH 8.0)
[33]. Following electrophoresis, gels were destained in
50% (v/v) methanol, 10% (v/v) glacial acetic acid and
subsequently washed several times in water before
visualization.
For immunodetection of mitochondrial proteins, samples
were resuspended in SIB and solubilized with DDM
or SMA as indicated. Supernatants were treated with
equivalent volumes of 2X sample buffer [140 mM Trizma,
20% (v/v) glycerol, 4% (w/v) sodium dodecyl sulfate,
0.05% (w/v) bromophenol blue, 0.25 M dithiothreitol]
and resolved by electrophoresis on 12% SDS-PAGE
gels. Following transfer onto nitrocellulose membranes,
Western blotting was performed with primary antibodies
against the Sdh3 subunit of respiratory Complex II
(Pacific Immunology) or against the Tim50 subunit of the
TIM23 Complex (a gift from Dr. Dejana Mokranjac) and
Amersham ECL Plex Cy5-conjugated secondary antibodies.
Immunoblots were imaged on a BioRad Pharos Plus
Molecular Imager using the Cy5 setting (635 nm laser
excitation, 695 nm emission filter).
Electron microscopy
For TEM imaging, SMA-solubilized mitochondria were
filtered (0.22 μm) and purified by size exclusion chroma-
tography on an AKTA Purifier system (GE Healthcare)
using a Superdex 200 10/300 GL column equilibrated
with 50 mM Tris (pH 8.0) and 200 mM NaCl. Purified
samples were adsorbed for 30 sec onto carbon-coated,
400-mesh copper grids (Ted Pella, Inc.) made hydrophilic
by glow discharge, washed with three drops of distilled
water and stained with 1% uranyl acetate. Images were
acquired using an AMT XR-40 (2048 × 2048 pixel) camera
mounted on a Tecnai Biotwin G2 Spirit transmission
electron microscope operated at 80 kV.
Complex IV activity assays and spectrophotometric
measurement of cytochromes
Respiratory Complex IV (cytochrome c oxidase) activity of
solubilized samples was determined spectrophotometrically
as described [48,49]. Equine cytochrome c (Sigma) was
reduced in the presence of ascorbate, purified by gel
filtration on a Sephadex G-50 column, and quantified
by absorbance at 550 nm (ε550nm = 27.6 mM
-1 cm-1)
[48]. To prepare samples for activity assays, mitochondria
were incubated with 1% (w/v) DDM, with SMA at a
concentration of 2 g SMA : 1 g mitochondrial protein, or
with SMA buffer only (mock SMA incubation) and treated
as described above. For SMA-solubilized and mock
incubation experiments, samples were filtered through a
0.4 μm membrane to remove fragmented mitochondrial
particulates that could contribute to enzyme activity. 120 μl
reaction mixtures containing assay buffer [50 mM
potassium phosphate (pH 7.4) and 50 μM EDTA]
with 30 μM reduced cytochrome c were added to a
quartz cuvette (path length 1 cm) and the reaction was
initiated by the addition of 20 μl of mitochondrial sample.
Cytochrome c oxidation kinetics were monitored by the
reduction of absorbance at 550 nm on an Ultrospec 2100
pro spectrophotometer over 180 s with 5 s measurement
intervals. Complex IV enzymatic rates were calculated
from the difference in absorbance at 550 nm over the
linear range (first 20 sec). For activity measurements of
samples fractionated by gel filtration, SMA-solubilized
particles were prepared as above and subjected to size
exclusion chromatography on a Superdex 200 10/300 GL
column equilibrated with assay buffer. Complex IV activity
was measured as above except that 1 ml fractions were
measured and 30 μM of reduced cytochrome c was added
to initiate the reaction. In all cases, parallel reactions
containing 4 mM potassium cyanide were assayed to
confirm specific Complex IV activity.
To assay the cytochrome content of DDM- and SMA-
treated mitochondria, samples were diluted 2X in buffer
[50 mM Tris (pH 8.0) 200 mM NaCl] in a 1 ml quartz
cuvette (path length 1 cm) and absorbance spectra were
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taken from 500 to 650 nm. Spectra of oxidized cyto-
chromes of respiratory chain enzymes were recorded first,
followed by spectra of fully reduced cytochromes in
the presence of 3 mM sodium dithionite. The difference
spectrum (reduced – oxidized) was used to calculate the
concentration of cytochrome a + a3 of Complex IV by the
peak of the alpha absorption band (604 nm) normalized by
the isobestic point (630 nm) using the differential extinction
coefficient value Δε603-630nm = 24 mM
-1 cm-1 [42,43].
Thin layer chromatography
Isolated mitochondria were incubated with SMA at a
concentration of 2 g SMA : 1 g mitochondrial protein
as above and subjected to filtration followed by incuba-
tion with a chloroform, methanol and water mixture
(final volume ratio of 1:2:1.6) to extract lipids. Extraction
was carried out for 1 h, followed by treatment with add-
itional chloroform and salt (final volume ratio of 1:1:1.25).
Phases were separated by low speed centrifugation and
extracted lipids were then collected, dried down, and
resuspended in 15 μl of chloroform. The entire volume
was then spotted onto a silica gel plate (Analtech). As
references, 1 μl each of POPC, POPE, and tetraoleoyl-CL
(Avanti Polar Lipids) were also spotted. Plates were placed
in a pre-equilbrated tank containing solvent (chloroform,
ethanol, water and triethylamine at volume ratios of
30:35:4:32) for 1.5 h [50] and visualized by aerospray
with molybdenum blue spray reagent (Sigma) [51].
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